title: A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review.
abstract: Thyrotropin (thyroid stimulating hormone [TSH]) secreting pituitary adenomas (TSHoma) are rare adenomas presenting with hyperthyroidism due to impaired negative feedback of thyroid hormone on the pituitary and inappropriate TSH secretion. This article presents a case of TSH-secreting macroadenoma without any clinical hyperthyroidism symptoms accompanying immunoreaction with growth hormone (GH) and prolactin. A 36-year-old female patient was admitted with complaints of irregular menses and blurred vision. On physical exam, she had bitemporal hemianopsia defect. Magnetic resonance imaging (MRI) evaluation showed suprasellar macroadenoma measuring 33 mm × 26 mm × 28 mm was detected on pituitary MRI. She had no hyperthyroidism symptoms clinically. Although free T4 and free T3 levels were elevated, TSH level was inappropriately within the upper limit of normal. Response to T3 suppression and thyrotropin releasing hormone-stimulation test was inadequate. Other pituitary hormones were normal. Transsphenoidal adenomectomy was performed due to parasellar compression findings. Immunohistochemically widespread reaction was observed with TSH, GH and prolactin in the adenoma. The patient underwent a second surgical procedure 2 months later due to macroscopic residual tumor, bitemporal hemianopsia and a suprasellar homogenous uptake with regular borders on indium-111 octreotide scintigraphy. After second surgery; due to ongoing symptoms and residual tumor, she was managed with octreotide and cabergoline treatment. On her follow-up with medical treatment, TSH and free T4 values were within normal limits. Although silent TSHomas are rare, they may arise with compression symptoms as in our case. The differential diagnosis of secondary hyperthyroidism should include TSHomas and thyroid hormone receptor resistance syndrome.
authors.affiliation: Department of Endocrinology and Metabolism, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey.
authors.forename: F
authors.initials: F
authors.lastname: Kuzu
authors.forename: T
authors.initials: T
authors.lastname: Bayraktaroğlu
authors.forename: F
authors.initials: F
authors.lastname: Zor
authors.forename: B D
authors.initials: BD
authors.lastname: G N
authors.forename: Y S
authors.initials: YS
authors.lastname: Salihoğlu
authors.forename: M
authors.initials: M
authors.lastname: Kalaycı
mesh_terms: D000236:Adenoma / Q000150:complications / Q000000981:diagnostic imaging / Q000378:metabolism*; D000328:Adult; D005260:Female; D006801:Humans; D006980:Hyperthyroidism; D007150:Immunohistochemistry; D008279:Magnetic Resonance Imaging; D015282:Octreotide / Q000031:analogs & derivatives; D010902:Pituitary Gland / Q000000981:diagnostic imaging; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000601:surgery; D011388:Prolactin; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood / Q000378:metabolism*
chemical_list: C094279:indium-111-octreotide; D011388:Prolactin; D013972:Thyrotropin; D015282:Octreotide